Higher expectations - Mounjaro at its highest dose (15mg) produces an average weight loss of 22.5% of body weight at 72 weeks, compared to 20.7% for Wegovy at its highest dose
These compounds support the first line of cell defense against the harmful effects of oxidative stress
To qualify for Wegovy, youll typically need one of the following: A BMI of 30 or higher (classified as obesity ), or A BMI of 27 or higher with at least one weight-related health condition Weight-related conditions may include: High blood pressure (hypertension) High cholesterol (dyslipidemia) Type 2 diabetes Heart disease Obstructive sleep apnea Polycystic ovary syndrome ( PCOS ) In addition, in March 2024 the FDA expanded Wegovys approval to include reducing the risk of major cardiovascular events like heart attac k, stroke, and cardiovascular death in adults with cardiovascular disease plus overweight or obesity
Any lesion that looks like the ugly duckling, meaning different from the patients other moles, deserves suspicion, as does one with a clear history of rapid evolution
DOI:10.1016/j.bcp.2019.02.008 [2]